C.Q. Pharmaceutical Holding: Announcement on the Progress of the Proposed Change in the Actual Controller.
C.Q. Pharmaceutical Holding: 2024 Interim Performance Forecast
C.Q. Pharmaceutical Holding: Investor Relations activity record on July 2nd, 2024.
C.Q. Pharmaceutical Holding: Announcement on the completion of the implementation of the plan for the company's chairman to increase shareholding and the results of the shareholding increase.
C.Q. Pharmaceutical Holding: Announcement of the results of the fifth short-term financing bond issuance of the holding subsidiary in 2024.
C.Q. Pharmaceutical Holding: Investor Relations Activity Records for June 14, 2024.
C.Q. Pharmaceutical Holding: Investor relations activity record form for June 12, 2024.
C.Q. Pharmaceutical Holding: Investor Relations Activity Record Form for June 11th, 2024.
C.Q. Pharmaceutical Holding: Summary of the Acquisition Report.
C.Q. Pharmaceutical Holding: Simplified Equity Change Report
C.Q. Pharmaceutical Holding: Announcement on Progress of Indirect Shareholder Signing the Agreement on Gratuitous Transfer and Intended Change of Actual Controller
C.Q. Pharmaceutical Holding: 2023 dividend payment implementation announcement
C.Q. Pharmaceutical Holding: May 28, 2024 Investor Relations Activity Record
C.Q. Pharmaceutical Holding: May 27, 2024 Investor Relations Activity Schedule
C.Q. Pharmaceutical Holding: May 24, 2024 Investor Relations Activity Schedule
C.Q. Pharmaceutical Holding: Voluntary Information Disclosure Notice on the Signing of the Strategic Cooperation Framework Agreement
C.Q. Pharmaceutical Holding: May 22, 2024 Investor Relations Activity Record
C.Q. Pharmaceutical Holding: May 20, 2024 Investor Relations Activity Schedule
C.Q. Pharmaceutical Holding: Lawyers of Beijing Jingtian Gongcheng Law Firm witness legal opinion on the 2023 Annual General Meeting of Shareholders of Heavy Pharmaceutical Holdings Co., Ltd.
C.Q. Pharmaceutical Holding: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
No Data